Australia markets closed

Poolbeg Pharma PLC (7JN.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.1370-0.0030 (-2.14%)
At close: 08:06AM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 74.58M
Enterprise value 58.06M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)3.61
Enterprise value/revenue N/A
Enterprise value/EBITDA -10.97

Trading information

Stock price history

Beta (5Y monthly) 2.26
52-week change 3101.44%
S&P500 52-week change 322.38%
52-week high 30.1400
52-week low 30.0645
50-day moving average 30.1059
200-day moving average 30.0891

Share statistics

Avg vol (3-month) 3129
Avg vol (10-day) 3N/A
Shares outstanding 5500M
Implied shares outstanding 6544.37M
Float 8421.63M
% held by insiders 122.66%
% held by institutions 16.08%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 June 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -5.57M
Net income avi to common (ttm)-4.89M
Diluted EPS (ttm)-0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)14.12M
Total cash per share (mrq)0.03
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)29.13
Book value per share (mrq)0.03

Cash flow statement

Operating cash flow (ttm)-4.94M
Levered free cash flow (ttm)N/A